まとめ
エピダーマルの成長因子 (EGF) は,A431細胞のフォスフォチロシンを急速に増加させ,新しいフォスフォタンパク質が現れます. この急速なチロシンリン酸化は,EGFに対する重要な早期対応であり,EGFの生物学的効果を媒介する可能性がある.
科学分野:
- 細胞生物学 細胞生物学
- 分子シグナル伝達です.
- バイオケミストリー バイオケミストリー
背景:
- 皮膚表皮成長因子 (EGF) は,細胞の成長と分化を調節する強力なミトゲンです.
- A431細胞は,EGF受容体シグナル伝達を研究するために一般的に使用されるヒト表皮がん細胞系である.
- フォスフォチロシンは,信号伝達経路に関与する重要な翻訳後の改変である.
研究 の 目的:
- A431細胞におけるEGF刺激による細胞タンパク質のリン酸化の急速な変化を調査する.
- EGFによって迅速に誘発される特定のフォスフォタンパク質を特定する.
- EGFに対する反応として,EGF受容体自体のリン酸化状態を調べる.
主な方法:
- EGFの生理学的濃度でA431細胞を処理する.
- 細胞タンパク質におけるフォスフォチロジン濃度の定量化.
- 分子重量分析を用いて,新たに現れたフォスフォプロテインの識別.
- EGF受容体のリン酸化パターンの分析.
主要な成果:
- EGFの刺激により,細胞のフォスフォチロシン濃度が急速に (1分以内に) そして持続的に (数時間以内に) 3~4倍増加した.
- フィブロブラスト成長因子やインスリンで,フォスフォチロジン濃度の有意な変化は観察されなかった.
- EGF添加後にフォスフォチロシンを含む2つの新しいフォスフォタンパク質 (39kDaと81kDa) が新たに検出されました.
- EGF受容体は,フォスフォチロシン,フォスフォセリン,フォスフォトレオニンを含有するフォスフォタンパク質であり,EGF治療でフォスフォリレーションパターンが変化していることが確認されました.
結論:
- タイロシンリン酸化の増加は,EGFに対する細胞反応の中で,これまでに確認された最も速い反応です.
- EGF受容体の特定のフォスフォタンパク質の急速な誘導とEGF受容体のリン酸化の変化は,EGFシグナル伝達における重要な早期イベントです.
- これらの急速なリン酸化現象は,EGFの多様な生物学的効果を媒介する上で重要な役割を果たしている可能性が高い.
さらに関連する動画
13:34A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
Published on: April 6, 2016
9.5K
06:54Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
13.1K
関連する概念動画
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
The Ras Gene
5.7K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
5.7K
mTOR Signaling and Cancer Progression
3.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.6K
Receptor Tyrosine Kinases
15.6K
Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
15.6K
MAPK Signaling Cascades
7.3K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.3K
PI3K/mTOR/AKT Signaling Pathway
5.2K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.2K
